SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

M&M, Zydus Lifesciences and Mastek to see some action today

Mastek Ltd. | IT - Software | IT & ITES | BSE: 523704 | NSE: MASTEK

19 Jul 2022 Evaluate

Mahindra & Mahindra (M&M) has executed an Option Exercise Share Purchase Agreement to acquire 1,317 Equity Shares of Sampo Rosenlew Oy, Finland, a subsidiary of the Company (Sampo) pursuant to exercise of a call option by the Company on the other Shareholder of Sampo. Pursuant to the said transaction, the Shareholding and consequent voting rights of the company in Sampo would increase from 79.13% to 100% of the Equity Share Capital of Sampo. Consequently, Sampo would become a wholly owned subsidiary of the company.

Zydus Lifesciences’ subsidiary -- Zydus Worldwide DMCC has received final approval from the United States Food and Drug Administration (USFDA) to market Efinaconazole Topical Solution, 10%. (US RLD: Jublia). Efinaconazole is an azole antifungal used for the topical treatment of Onychomycosis of the toenails due to Trichophyton rubrum and Trichophyton mentagrophytes.

Mastek has announced the signing of a definitive agreement to acquire MST Solutions. MST Solutions is based in Chandler, AZ, and is an independent Salesforce consulting partner in the Americas region. MST is a trusted partner to several Fortune 1000 and large enterprise clients. MST has built a strong reputation for themselves especially in the Healthcare, Public Sector and Manufacturing Industry verticals.

Mahindra Logistics has received approval for incorporation of new wholly owned subsidiaries of the Company, one each in India namely ‘V-Link Freight Services’ and in United Kingdom namely ‘MLL Global Logistics’. This in line with the Company's vision to further address growth opportunities in logistics and will also establish international presence. Post initial investment by the company, the new companies will become wholly owned subsidiaries of the company.

Yes Bank is planning to invest up to Rs 350 crore for a potential 20 percent stake in asset reconstruction company JC Flowers, which has emerged as the base bidder for the lender's bad loans worth Rs 48,000 crore. It is planning to raise up to $1 billion in FY23 to bolster its core capital base once the NPA challenge is over.

Surya Roshni has obtained orders amounted to Rs 91.27 crore (including GST) for supply of API- 5L 3LPE Coated Line pipes from Bharat Gas Resources.

Adani Wilmar has further slashed edible oil prices by up to Rs 30 per litre amid a fall in global prices. The maximum reduction has been done in soyabean oil. The stocks with new prices will reach the market soon. Fortune soyabean oil price has been revised to Rs 165 per litre from Rs 195 per litre. The sunflower oil rate has been revised to Rs 199 per litre from Rs 210 per litre. Mustard Oil MRP (maximum retail price) has been cut to Rs 190 per litre from Rs 195 per litre.

Mastek Share Price

1688.00 -56.90 (-3.26%)

20-Apr-2026 15:31 View Price Chart

Peers

Company Name	CMP
TCS	2573.90
Infosys	1310.50
HCL Tech.	1427.50
Wipro	202.55
Tech Mahindra	1500.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

M&M, Zydus Lifesciences and Mastek to see some action today

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.